2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one

C26H30N6O3 — CID 122281443

IUPAC2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one
SMILESCCOc1ccc(-c2ccc(=O)n(C(C)C(=O)N3CCN(c4cc5c(nn4)CCC5)CC3)n2)cc1
InChIInChI=1S/C26H30N6O3/c1-3-35-21-9-7-19(8-10-21)23-11-12-25(33)32(29-23)18(2)26(34)31-15-13-30(14-16-31)24-17-20-5-4-6-22(20)27-28-24/h7-12,17-18H,3-6,13-16H2,1-2H3
InChIKeyYDSRGPYHLXCKPA-UHFFFAOYSA-N
MW474.57 g/mol
LogP2.50
Rot. Bonds6

About 2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one

2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one (PubChem CID 122281443) has the molecular formula C26H30N6O3 and a molecular weight of 474.57 g/mol. Its IUPAC name is 2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one.

Molecular Properties

Compound Name2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one
PubChem CID122281443
Molecular FormulaC26H30N6O3
Molecular Weight474.57 g/mol
Exact Mass474.24
IUPAC Name2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one
SMILESCCOc1ccc(-c2ccc(=O)n(C(C)C(=O)N3CCN(c4cc5c(nn4)CCC5)CC3)n2)cc1
InChIInChI=1S/C26H30N6O3/c1-3-35-21-9-7-19(8-10-21)23-11-12-25(33)32(29-23)18(2)26(34)31-15-13-30(14-16-31)24-17-20-5-4-6-22(20)27-28-24/h7-12,17-18H,3-6,13-16H2,1-2H3
InChIKeyYDSRGPYHLXCKPA-UHFFFAOYSA-N
XLogP2.50
TPSA93.45 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500474.57
LogP ≤ 52.50
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze 2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one?
The IUPAC name of 2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one (CID 122281443) is 2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one.
What is the SMILES notation for 2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one?
The canonical SMILES for 2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one is CCOc1ccc(-c2ccc(=O)n(C(C)C(=O)N3CCN(c4cc5c(nn4)CCC5)CC3)n2)cc1.
What is the InChIKey of 2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one?
The InChIKey is YDSRGPYHLXCKPA-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H30N6O3/c1-3-35-21-9-7-19(8-10-21)23-11-12-25(33)32(29-23)18(2)26(34)31-15-13-30(14-16-31)24-17-20-5-4-6-22(20)27-28-24/h7-12,17-18H,3-6,13-16H2,1-2H3.
What are the key properties of 2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one?
2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one has a molecular weight of 474.57 g/mol, XLogP of 2.50, 6 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[1-[4-(6,7-dihydro-5H-cyclopenta[c]pyridazin-3-yl)piperazin-1-yl]-1-oxopropan-2-yl]-6-(4-ethoxyphenyl)pyridazin-3-one is sourced from PubChem (CID 122281443), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).